News
BLCO
16.01
-1.60%
-0.26
Weekly Report: what happened at BLCO last week (0504-0508)?
Weekly Report · 4d ago
A Look At Bausch + Lomb (BLCO) Valuation After Bi Blade Plus Launch In European Surgical Market
Simply Wall St · 4d ago
Jazz, AstraZeneca, Astellas: Foreign Healthcare's strongest Quant picks
Seeking Alpha · 05/07 11:50
Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe
Barchart · 05/07 06:00
Bausch + Lomb Announces Second R&D “Teach-in” Webinar
Barchart · 05/06 06:15
Will Stronger 2026 Guidance And ARVO Data Shift Bausch + Lomb's (BLCO) Innovation-Led Growth Narrative?
Simply Wall St · 05/06 03:26
Most and least shorted mid-to mega-cap healthcare stocks in May
Seeking Alpha · 05/04 13:35
H.C. Wainwright Remains a Buy on Bausch + Lomb Corporation (BLCO)
TipRanks · 05/04 10:36
Weekly Report: what happened at BLCO last week (0427-0501)?
Weekly Report · 05/04 10:02
Bausch + Lomb Lifts Outlook After Margin-Heavy Quarter
TipRanks · 05/01 01:09
Bausch + Lomb (BLCO) Starts 2026 With Ongoing Losses That Test Bullish Margin Narratives
Simply Wall St · 04/30 22:12
Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (REGN), Bausch + Lomb Corporation (BLCO) and Indivior (INDV)
TipRanks · 04/30 16:50
Bausch + Lomb price target lowered to $16 from $17 at Evercore ISI
TipRanks · 04/30 16:45
Stifel Nicolaus Keeps Their Hold Rating on Bausch + Lomb Corporation (BLCO)
TipRanks · 04/30 15:26
Bausch + Lomb (BLCO) Q1 2026 Earnings Transcript
The Motley Fool · 04/30 15:17
Evercore ISI Group Maintains In-Line on Bausch & Lomb, Lowers Price Target to $16
Benzinga · 04/30 14:56
Bausch + Lomb price target lowered to $16 from $18 at Deutsche Bank
TipRanks · 04/30 14:24
Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), Regeneron (REGN)
TipRanks · 04/30 12:04
Bausch + Lomb price target lowered to C$19 from C$21 at Citi
TipRanks · 04/30 11:48
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Align Tech (ALGN) and Bausch + Lomb Corporation (BLCO)
TipRanks · 04/30 09:12
More
Webull provides a variety of real-time BLCO stock news. You can receive the latest news about Bausch + Lomb Corporation through multiple platforms. This information may help you make smarter investment decisions.
About BLCO
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.